| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of Medicine, Biochemistry and Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106
Simultaneous synthesis and breakdown of glycogen is called glycogen cycling. The extent of hyperglycemia and decreased glycogen stores in diabetes mellitus may relate in part to the extent cycling occurs. Four methods have been introduced to estimate its extent in liver in humans. 1) In the fasted state, the rate of net hepatic glycogenolysis, i.e., glycogen breakdown minus synthesis, is estimated using NMR, and the rate of glycogenolysis is estimated from deuterium labeling of blood glucose on 2H2O ingestion. 2) The rate of glycogen synthesis is estimated from the rate of labeling of carbon 1 of glycogen on [1-13C]glucose infusion, monitored by NMR, and the rate of breakdown from the rate of disappearance of that labeling on unlabeled glucose infusion. 3) The rate of synthesis from glucose-1-P, formed by glycogenolysis, is measured by the decrease in the 3H/14C ratio in acetaminophen glucuronide on acetaminophen and [2-3H,6-14C]galactose administration. 4) The rate of synthesis is estimated from the dilution of label from labeled galactose in its conversion to the acetaminophen glucuronide, and the rate of glycogenolysis is estimated from the amount of label in blood glucose. In the first method, the fate of glucose-6-P is assumed to be only to glycogen and glucose. In the second, only glucose-6-P molecules formed by breakdown that are not cycled back to glycogen are measured. In the third, 3H is assumed to be removed completely during cycling, and only the molecules cycled back to glycogen are measured. In the fourth, galactose conversion to glucose is assumed to be via glycogen. Quantitations in all four methods depend on assuming the order in which the molecules deposited in glycogen are released.
liver; glycogenolysis; gluconeogenesis; glycogenesis
This article has been cited by other articles:
|
|
 |
|
  P. Staehr, O. Hother-Nielsen, H. Beck-Nielsen, M. Roden, H. Stingl, J. J. Holst, P. K. Jones, V. Chandramouli, and B. R. Landau Hepatic autoregulation: response of glucose production and gluconeogenesis to increased glycogenolysis Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1265 - E1269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Oz, E. R. Seaquist, A. Kumar, A. B. Criego, L. E. Benedict, J. P. Rao, P.-G. Henry, P.-F. Van De Moortele, and R. Gruetter Human brain glycogen content and metabolism: implications on its role in brain energy metabolism Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E946 - E951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kishore, I. Gabriely, M.-H. Cui, J. Di Vito, S. Gajavelli, J.-H. Hwang, and H. Shamoon Role of Hepatic Glycogen Breakdown in Defective Counterregulation of Hypoglycemia in Intensively Treated Type 1 Diabetes Diabetes, March 1, 2006; 55(3): 659 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Krssak, A. Brehm, E. Bernroider, C. Anderwald, P. Nowotny, C. D. Man, C. Cobelli, G. W. Cline, G. I. Shulman, W. Waldhausl, et al. Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes Diabetes, December 1, 2004; 53(12): 3048 - 3056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, W. F. Schwenk, and R. A. Rizza Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E55 - E62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Nielsen, A. Caumo, V. Chandramouli, W. C. Schumann, C. Cobelli, B. R. Landau, H. Vilstrup, R. A. Rizza, and O. Schmitz Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E102 - E110. [Abstract] [Full Text]
|
|
|
|
|
|
S. P. Kim, M. Ellmerer, G. W. Van Citters, and R. N. Bergman Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog Diabetes, October 1, 2003; 52(10): 2453 - 2460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kunert, H. Stingl, E. Rosian, M. Krssak, E. Bernroider, W. Seebacher, K. Zangger, P. Staehr, V. Chandramouli, B.R. Landau, et al. Measurement of Fractional Whole-Body Gluconeogenesis in Humans From Blood Samples Using 2H Nuclear Magnetic Resonance Spectroscopy Diabetes, October 1, 2003; 52(10): 2475 - 2482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Woerle, C. Meyer, J. M. Dostou, N. R. Gosmanov, N. Islam, E. Popa, S. D. Wittlin, S. L. Welle, and J. E. Gerich Pathways for glucose disposal after meal ingestion in humans Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E716 - E725. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
